| Literature DB >> 19583682 |
E Montané1, A Barriocanal, I Isern, T Parajon, J Costa.
Abstract
Serotonin syndrome is a potentially life-threatening disorder of excessive serotoninergic activity often due to drug interactions. We report a case of serotonin syndrome induced by pharmacokinetic and pharmacodynamic interactions between three different selective serotonin-reuptake inhibitors (SSRI) and possibly ciprofloxacin. Extreme caution is necessary in patients treated with serotonin-reuptake inhibitors who need to be switched to another antidepressant or when they require the addition of concomitant drugs, especially serotoninergic drugs and isoenzimes of cytochrome P450 inhibitors.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19583682 DOI: 10.1111/j.1365-2710.2009.01023.x
Source DB: PubMed Journal: J Clin Pharm Ther ISSN: 0269-4727 Impact factor: 2.512